Source link : https://newshealth.biz/health-news/abemaciclib-ups-overall-survival-in-high-risk-breast-cancer/
Adding the CDK4/6 inhibitor abemaciclib to endocrine therapy significantly improves overall survival in node-positive, high-risk early breast cancer, in the extended follow-up of a landmark trial. Medscape Medical News Source link : https://www.medscape.com/viewarticle/abemaciclib-ups-overall-survival-high-risk-breast-cancer-2025a1000san?src=rss Author : Publish date : 2025-10-18 14:25:00 Copyright for syndicated content belongs to the linked Source.
The post Abemaciclib Ups Overall Survival in High-Risk Breast Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2025-10-18 14:25:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8